Hospitals, pharmaceutical companies and other
Intelligent Medicine Exchange, which received approval from the
“These tools get to the core of the business,” James Plante, IMX’s co-founder and chief executive officer, said in an interview. “It’s a very efficient way to solve for cost transparency, the biggest problem ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.